Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by argentia77on Jan 25, 2016 6:27pm
145 Views
Post# 24492065

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Short selling could very well be the reason for 30% decline

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Short selling could very well be the reason for 30% declineOutperformRX:  "OK, I listen again and he says Concordia is only player that can buy products on the global market." Well now you mistaken. CEO said Concordia is the only SPECIALTY PHARMA company that can do what they do globally.  Novartis is not a specialty pharma company. It's at minute 6:57 in his CIBC presentation which you can listen to here: https://webcasts.welcome2theshow.com/cibcwhistler2016/concordia
<< Previous
Bullboard Posts
Next >>